carpal tunnel syndrom.
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Nocturnal paresthesia / dysplasia with or without excessive pain on the hands Numbness In the sensory distribution of the median nerve Weakness with atrophic changes in the Median nerve innervated Positive Phalen or Tinel test Age 20 to 80 years They have mild to moderate CTS and their symptoms last for more than three months And have been resistant to drug therapy and splints conscious patient satisfaction
Exclusion criteria
Exclusion criteria: History of polyneuropathy History of inflammatory arthritis Current use of warfarin Previous steroid injection for CTS Trauma at the injection site Allergy to corticosteroid skin infection at the injection site neoplasm at the injection site History of Brachial plexiopathy History of thoracic outlet syndrome History of wrist surgery History of hypothyroidism History of pregnancy History of rheumatic disorders History of having a pacemaker
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intensity of pain. Timepoint: before intervention, 1 month after intervention, 3 months after intervention. Method of measurement: A 10-point VAS scale that the patient should give a score from 0 to 10.;Evaluation of patient performance with Boston questionnaire. Timepoint: before intervention, 1 month after intervention, 3 months after intervention. Method of measurement: Boston Questionnaire Score.;Electrodiagnostic criteria. Timepoint: before intervention, 1 month after intervention, 3 months after intervention. Method of measurement: Based on the latency duration and amp intensity in SNAP, CMAP median nerve, we determine the severity of involvement and recovery. | — |
Countries
Iran (Islamic Republic of)
Contacts
Artesh University of Medical Sciences